Insulet Corporation (PODD) analyst actions
PODD analyst actions moved a median of -0.20% by the close. Rating and price-target actions on PODD in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the PODD overview →
10 measured PODD analyst action events.
| Middle 50% of PODD analyst action reactions | -1.55% to +0.75% |
|---|---|
| Median reaction (to close) | -0.20% |
| Measured reactions | 10 |
Half of the 10 PODD analyst action events with a measured close landed between -1.55% and +0.75%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bronstein, Gewirtz & Grossman (PODD) And Encourages Shareholders to Reach Out | Press release | +0.51% | +0.17% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Insulet Corporation (PODD) And Encourages Stockholders to Reach Out | Press release | +0.51% | +0.17% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bronstein, Gewirtz & Grossman (PODD) And Encourages Stockholders to Reach Out | Press release | -0.17% | -0.57% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Insulet Corporation (PODD) And Encourages Shareholders to Reach Out | Press release | +0.07% | +0.95% | |
| Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets | Press release | -1.85% | +1.40% | |
| Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes | Press release | +0.07% | -2.08% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bronstein, Gewirtz & Grossman, LLC (PODD) And Encourages Stockholders to Reach Out | Press release | -0.11% | -1.25% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Insulet Corporation (PODD) And Encourages Shareholders to Reach Out | Press release | +0.43% | +1.01% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Insulet Corporation (PODD) And Encourages Stockholders to Reach Out | Press release | -0.43% | -1.65% | |
| Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S. | Press release | -0.94% | -3.07% |
More PODD: earnings → · SEC filings → · PODD overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Biogen Inc. (BIIB) | 1,208 | -0.01% | 49% |
| Rocket Pharmaceuticals, Inc. (RCKT) | 1,202 | -0.02% | 47% |
| Invacare Corporation (IVC) | 1,193 | 0.00% | 49% |
| ICON plc - Ordinary Shares (ICLR) | 1,176 | -0.01% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.